Williams Donald A.'s most recent trade in Palisade Bio Inc was a trade of 5,000 Common Stock done at an average price of $1.9 . Disclosure was reported to the exchange on Jan. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | Donald A. Williams | Director | Purchase of securities on an exchange or from another person at price $ 1.88 per share. | 09 Jan 2026 | 5,000 | 5,728 | - | 1.9 | 9,400 | Common Stock |
| Palisade Bio Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2025 | 1,538,700 | 1,538,700 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2025 | 182,000 | 182,000 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 64,400 | 64,400 | - | - | Phantom Units | |
| Palisade Bio Inc | Donald A. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2024 | 388 | 728 | - | 0 | Comon Stock, par value $0.01 | |
| Forte Biosciences Inc | Donald A. Williams | Director | 20 Aug 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | ||
| Palisade Bio Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2024 | 2,100 | 2,100 | - | - | Common Stock Options | |
| Palisade Bio Inc | Donald A. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 340 | 340 | - | 0 | Comon Stock, par value $0.01 | |
| Palisade Bio Inc | Donald A. Williams | Director | Purchase of securities on an exchange or from another person at price $ 4.86 per share. | 28 May 2024 | 1,000 | 1,000 | - | 4.9 | 4,863 | Comon Stock, par value $0.01 |
| Palisade Bio Inc | Williams Donald A. | Director | Purchase of securities on an exchange or from another person at price $ 0.60 per share. | 31 Jan 2024 | 10,000 | 30,000 | - | 0.6 | 6,050 | Common Stock, par value $0.01 |
| Forte Biosciences Inc | Donald A. Williams | Director | 31 Jul 2023 | 59,405 | 59,405 | - | 1.0 | 59,999 | Common Stock | |
| Palisade Bio Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 12,160 | 12,160 | - | - | Common Stock Options | |
| Palisade Bio Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 5,100 | 5,100 | - | - | Restricted Stock Units | |
| Forte Biosciences Inc | Donald A. Williams | Director | 01 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | ||
| Forte Biosciences Inc | Donald A. Williams | Director | 23 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | ||
| Alphatec Holdings Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 10,221 | 134,728 (0%) | 0% | 0 | Common Stock | |
| Forte Biosciences Inc | Donald A. Williams | Director | 28 May 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | ||
| Palisade Bio Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 10,203 | 10,203 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Donald A. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 4,406 | 4,406 | - | - | Stock Option (Right to Buy) |